EP1128796A1 - Nipple for nursing bottle - Google Patents

Nipple for nursing bottle

Info

Publication number
EP1128796A1
EP1128796A1 EP99942982A EP99942982A EP1128796A1 EP 1128796 A1 EP1128796 A1 EP 1128796A1 EP 99942982 A EP99942982 A EP 99942982A EP 99942982 A EP99942982 A EP 99942982A EP 1128796 A1 EP1128796 A1 EP 1128796A1
Authority
EP
European Patent Office
Prior art keywords
teat
sleeve
nipple
injection means
bottle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP99942982A
Other languages
German (de)
French (fr)
Other versions
EP1128796B1 (en
Inventor
Hubert Andre De L'arc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1128796A1 publication Critical patent/EP1128796A1/en
Application granted granted Critical
Publication of EP1128796B1 publication Critical patent/EP1128796B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J11/00—Teats
    • A61J11/0005—Teats having additional ports, e.g. for connecting syringes or straws
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0015—Devices specially adapted for taking medicines
    • A61J7/0046—Cups, bottles or bags
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0015—Devices specially adapted for taking medicines
    • A61J7/0053—Syringes, pipettes or oral dispensers

Definitions

  • the present invention relates to a liquid delivery device by means of a teat adapting to an ordinary bottle.
  • a teat conventionally comprises a distal part and a proximal part separated by a middle part.
  • Patent US-A-2 680 441 which proposes to insert at the nipple a conduit opening at the nipple of the nipple in the proximal part so as, as indicated in this document, to inject the drug into the child's mouth.
  • the conduit is connected to an injection means, a syringe for example.
  • This system has mechanical drawbacks on the one hand because the connection between the conduit and the teat is not reliable and poses sterilization problems, and on the other hand retains the drawbacks of direct administration of the drug dose indicated above. above since the dose is injected directly into the child's mouth.
  • US-A-5,178,291 which provides a bottle equipped with a nursing cover separating the nipple of the teat from the body of the bottle, on which is mounted a reservoir containing a dose of vitamin.
  • the reservoir is connected to the nipple of the teat by a conduit so that the suction of the nipple leads to the aspiration by the child of said dose.
  • the system described has all the drawbacks previously noted and moreover requires the presence of a cover.
  • the connection between the conduit and the teat is not clearly explained, but the structure described requires an injection of the drug product into the bottle at the distal part and not in the middle part of the teat since the conduit is inserted between the bead and the nipple of the pacifier. There is therefore the drawback of mixing the drug product with the food bowl.
  • the object of the present invention is to remedy these drawbacks by providing a device making it possible to very easily administer a liquid or solid medicinal product while taking the bottle, and this, at any time during feeding.
  • the subject of the invention is therefore a teat for a baby bottle of the type comprising a proximal part extended by a nipple and a distal part separated by a middle part for the administration of a medicinal product together with the food bolus, characterized in that it comprises a hollow sleeve, one end of which is fixed at the level of the median part to open into the latter at a point distant from the proximal part and the other end of which is connected to a means for injecting the drug product , to ensure the mixing of said medicinal product with the part of the food bolus contained in the middle part of the teat.
  • the sleeve is integrated into the middle part to constitute a single piece.
  • the end of the sleeve connected to the injection means has a frustoconical profile to allow the gradual insertion of said injection means.
  • the sleeve is implanted far enough from the proximal part to avoid any interference with the feeding process.
  • the angle ⁇ of implantation of the sleeve on the middle part is between approximately 30 and 90 °.
  • the sleeve is made of the same material as that of the teat itself.
  • a very first advantage of the present invention lies in the fact that the administration of the drug can be carried out at the start of the meal, but in admixture with its diet. The child will therefore receive his medicine without really realizing it since he will be mixed only with the fraction of his food bowl present in the middle part of the teat. There will be no more trace taste after the passage of the drug, the rest of the bottle will have a normal taste since there will be no mixture with the drug product contained in the bottle.
  • Another advantage of the present invention lies in the ease of cleaning and disinfection of the modified teat. Indeed, the teat and the sleeve are treated and cleaned in the same way without any particular difficulty.
  • FIG. 1 represents in section the teat according to the invention
  • FIG. 2 shows a teat mounted on a standard bottle with an injection means containing the product to be administered.
  • the section of the teat 1 shown in Figure 1 shows a conventional teat consisting of a proximal part P extended by a nipple 2 pierced at its end, with a distal part D separated by a middle part M.
  • the middle part M can be presented either, as illustrated in the figure, in the form of a bulge 3, or under a more or less tubular shape.
  • the distal part is conventionally provided at its base with a belt 4 allowing its adaptation in the ring of the bottle.
  • the teat is made of a material traditionally used in the manufacture of this kind of product and meeting the standards in force.
  • the teat is equipped according to the invention with a hollow sleeve 5 fixed at one end to the middle part M shown as close as possible to the belt 4 and away from the nipple 2 by opening into the bulge 3.
  • the sleeve 5 is made of the same material as that of the teat.
  • the free end 6 of the sleeve receives an injection means 7, a pipette for example.
  • This sleeve has a frustoconical shape, the large base being located at the free end 6, which ensures sealing against air and liquid for all types of pipette.
  • the sleeve may consist of a tubular part followed by a frustoconical part.
  • the sleeve 5 therefore constitutes an integral part of the nipple 1, this in particular in the case where the device is made of a material, of the rubber or silicone type, in a single injection molding operation.
  • This sleeve can be placed in a rectilinear manner with respect to the teat, but we will adopt a curved shape in an arc of a circle whose curvature is directed towards the teat.
  • this sleeve 5 can be oriented in any way with respect to the teat, but it is preferred to place it at an angle ⁇ between 30 and 90 ° relative to the longitudinal axis XX of the teat.
  • the frustoconical part of the sleeve will be provided so that the majority of pipettes sold adapt to it at its free end both easily and holds there in an airtight and liquid tight manner.
  • the length and elasticity of the hollow sleeve will be sufficient to maintain the injection means even when letting go of it and also not to hinder the positioning of the teat in the ring of the bottle.
  • the size of the teat will be sufficient so that the child's mouth is not hampered by the birth of the sleeve.
  • the principle of administration of the drug dose according to the invention is shown diagrammatically in this figure.
  • a volume V is formed in the middle part M, in which the concentrated mixture is mainly located, which is immediately sucked up by the child under normal conditions of use. There is therefore no reflux in the bottle prejudicial to good administration of the drug product, nor injection at the level of the proximal part.
  • a zone v less rich in drug product can form, but it is also quickly swallowed by the child.
  • FIG 2 there is shown the establishment of an injection means 7 pre-filled in the sleeve 5.
  • This means can be used as shown in the figure or be removably secured with the bottle 8 equipped with its ring 10 for ease of use.
  • To administer the required dose simply give the child the bottle as usual, then actuate the piston 9 of the injection means 7 when desired so that the drug product contained empties directly into the part median of the nipple during feeding to form volume V.
  • the user When the child takes his bottle, the user only has to press, the chosen moment, on the piston and the drug product will empty in the immediate vicinity of the teat 1 outlet orifice, mixing with the meal of the child at the middle part.
  • the invention therefore allows the administration of medicated or other liquids using a teat while being certain of the complete intake of the product while limiting the usual causes of refusal of the child (taste and odor).
  • the product thus administered will only remain in the teat for a short time and will be quickly swallowed. There will no longer be any traces of taste after administration.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • External Artificial Organs (AREA)
  • Surgical Instruments (AREA)
  • Table Equipment (AREA)

Abstract

The invention concerns a nipple (1) for a nursing bottle comprising a proximal portion P extended by a teat (2) and a distal portion D separated by a median portion M for administering a medicinal product together with an alimentary bolus. The nipple comprises a hollow sleeve (5) whereof one end is fixed to a bulge (3) at a point spaced away from the teat at the median portion and whereof the other end (6) is connected to means injecting (7) the medicinal liquid, to ensure that the medicinal product is mixed with the alimentary bolus contained in the nipple in its median portion. The sleeve (5) is integral with the median portion bulge and its end linked to the injection means (7) with a tapering profile for gradual insertion of said injection means. The invention is useful for medical treatment of children.

Description

TETINE POUR BIBERON D'ENFANT TEAT FOR CHILD BOTTLE
La présente invention concerne un dispositif d'administration de liquide par le biais d'une tétine s' adaptant à un biberon ordinaire. Une tétine comprend classiquement une partie distale et une partie proximale séparée par une partie médiane.The present invention relates to a liquid delivery device by means of a teat adapting to an ordinary bottle. A teat conventionally comprises a distal part and a proximal part separated by a middle part.
Il est bien connu qu'il est difficile de faire boire certains médicaments aux petits enfants à cause de leur mauvais goût ou de leur odeur. Dans certaines boîtes de médicament, on fournit une pipette graduée pour faciliter leur administration, et donner la dose exacte correspondant au poids corporel. Mais cela ne modifie ni le goût, ni l'odeur et on aboutit à un refus de l'enfant qu'il est difficile de vaincre. Mélanger le produit médicamenteux au lait du biberon ne permet pas toujours la prise complète du liquide car un enfant malade peut ne pas finir bien souvent son repas. La quantité exacte de médicament administrée est de ce fait parfois inférieure à la posologie préconisée et bien entendu inconnue. C'est une des causes d' échec thérapeutique. On connaît le brevet US-A-2 680 441 qui propose d'insérer au niveau de la tétine un conduit débouchant au niveau du mamelon de la tétine dans la partie proximale de façon à, comme indiqué dans ce document, injecter le médicament dans la bouche de l'enfant. Bien entendu, le conduit est relié à un moyen d'injection, une seringue par exemple. Ce système présente d'une part des inconvénients mécaniques car la liaison entre le conduit et la tétine n' est pas fiable et pose des problèmes de stérilisation, et d' autre part conserve les inconvénients d'administration directe de la dose médicamenteuse signalés ci- dessus puisque la dose est injectée directement dans la bouche de l'enfant.It is well known that it is difficult to make certain children drink certain medicines because of their bad taste or smell. In some drug boxes, a graduated pipette is provided to facilitate administration, and to give the correct dose for body weight. But this does not change the taste or the smell and we end up with a refusal by the child that is difficult to overcome. Mixing the drug product with milk from the bottle does not always allow complete intake of the liquid because a sick child may not finish his meal very often. The exact amount of drug administered is therefore sometimes lower than the recommended dosage and of course unknown. It is one of the causes of therapeutic failure. Patent US-A-2 680 441 is known which proposes to insert at the nipple a conduit opening at the nipple of the nipple in the proximal part so as, as indicated in this document, to inject the drug into the child's mouth. Of course, the conduit is connected to an injection means, a syringe for example. This system has mechanical drawbacks on the one hand because the connection between the conduit and the teat is not reliable and poses sterilization problems, and on the other hand retains the drawbacks of direct administration of the drug dose indicated above. above since the dose is injected directly into the child's mouth.
On connaît également le brevet US-A-5 178 291 qui propose un biberon équipé d'un couvercle d'allaitement séparant le mamelon de la tétine du corps du biberon, sur lequel est monté un réservoir contenant une dose de vitamine. CommeAlso known is US-A-5,178,291 which provides a bottle equipped with a nursing cover separating the nipple of the teat from the body of the bottle, on which is mounted a reservoir containing a dose of vitamin. As
FFIÏÏT.T.R DE REMPLACEMENT (REGLE 26) précisé dans ce brevet, le réservoir est relié au mamelon de la tétine par un conduit de telle façon que la succion du mamelon conduise à l'aspiration par l'enfant de ladite dose. Mais le système décrit présente tous les inconvénients précédemment relevés et de plus impose la présence d'un couvercle. D'autre part, la liaison entre le conduit et la tétine n'est pas clairement explicitée, mais la structure décrite impose une injection du produit médicamenteux dans le biberon au niveau de la partie distale et non pas dans la partie médiane de la tétine puisque le conduit est inséré entre le bourrelet et le mamelon de la tétine. On retrouve donc l'inconvénient du mélange du produit médicamenteux avec le bol alimentaire.REPLACEMENT FFIÏÏT.TR (RULE 26) specified in this patent, the reservoir is connected to the nipple of the teat by a conduit so that the suction of the nipple leads to the aspiration by the child of said dose. But the system described has all the drawbacks previously noted and moreover requires the presence of a cover. On the other hand, the connection between the conduit and the teat is not clearly explained, but the structure described requires an injection of the drug product into the bottle at the distal part and not in the middle part of the teat since the conduit is inserted between the bead and the nipple of the pacifier. There is therefore the drawback of mixing the drug product with the food bowl.
Le but de la présente invention est de remédier à ces inconvénients en fournissant un dispositif permettant d'administrer très facilement un produit médicamenteux liquide ou solide pendant la prise du biberon, et ce, à n'importe quel moment de la tétée.The object of the present invention is to remedy these drawbacks by providing a device making it possible to very easily administer a liquid or solid medicinal product while taking the bottle, and this, at any time during feeding.
L'invention a donc pour objet une tétine pour biberon d' enfant du type comportant une partie proximale prolongée par un mamelon et une partie distale séparées par une partie médiane pour l'administration d'un produit médicamenteux conjointement avec le bol alimentaire, caractérisée en ce qu' elle comporte un manchon creux dont une extrémité est fixée au niveau de la partie médiane pour déboucher dans celle-ci en un point éloigné de la partie proximale et dont l'autre extrémité est connectée à un moyen d'injection du produit médicamenteux, pour assurer le mélange dudit produit médicamenteux avec la partie du bol alimentaire contenue dans la partie médiane de la tétine.The subject of the invention is therefore a teat for a baby bottle of the type comprising a proximal part extended by a nipple and a distal part separated by a middle part for the administration of a medicinal product together with the food bolus, characterized in that it comprises a hollow sleeve, one end of which is fixed at the level of the median part to open into the latter at a point distant from the proximal part and the other end of which is connected to a means for injecting the drug product , to ensure the mixing of said medicinal product with the part of the food bolus contained in the middle part of the teat.
Le manchon est intégré à la partie médiane pour constituer une pièce unique.The sleeve is integrated into the middle part to constitute a single piece.
L'extrémité du manchon liée au moyen d'injection présente un profil tronconique pour permettre l'insertion graduelle dudit moyen d'injection. Le manchon est implanté de façon suffisamment éloignée de la partie proximale pour éviter toute gène du processus de tétée.The end of the sleeve connected to the injection means has a frustoconical profile to allow the gradual insertion of said injection means. The sleeve is implanted far enough from the proximal part to avoid any interference with the feeding process.
L' angle α d' implantation du manchon sur la partie médiane est compris entre environ 30 et 90°.The angle α of implantation of the sleeve on the middle part is between approximately 30 and 90 °.
Le manchon est réalisé dans le même matériau que celui de la tétine elle-même.The sleeve is made of the same material as that of the teat itself.
La partie médiane se présente sous la forme d'un renflement. Un tout premier avantage de la présente invention réside dans le fait que l'administration du médicament peut être réalisée au début du repas, mais en mélange avec son alimentation. L'enfant recevra donc son médicament sans vraiment s'en rendre compte puisqu'il sera mélangé seulement à la fraction de son bol alimentaire présente dans la partie médiane de la tétine. Il ne restera plus de trace gustative après le passage du médicament, le reste du biberon aura un goût normal puisqu' il n' y aura pas de mélange avec le produit médicamenteux contenu dans le biberon. Un autre avantage de la présente invention réside dans la facilité de nettoyage et de désinfection de la tétine modifiée. En effet, la tétine et le manchon sont traités et nettoyés de la même manière sans difficulté particulière.The middle part is in the form of a bulge. A very first advantage of the present invention lies in the fact that the administration of the drug can be carried out at the start of the meal, but in admixture with its diet. The child will therefore receive his medicine without really realizing it since he will be mixed only with the fraction of his food bowl present in the middle part of the teat. There will be no more trace taste after the passage of the drug, the rest of the bottle will have a normal taste since there will be no mixture with the drug product contained in the bottle. Another advantage of the present invention lies in the ease of cleaning and disinfection of the modified teat. Indeed, the teat and the sleeve are treated and cleaned in the same way without any particular difficulty.
D'autres caractéristiques, détails et avantages de l'invention apparaîtront plus clairement à la lecture du complément de description donné ci-après d'un mode de réalisation donné à titre d'illustration en relation avec des dessins sur lesquels : la figure 1 représente en coupe la tétine selon l'invention,Other characteristics, details and advantages of the invention will appear more clearly on reading the additional description given below of an embodiment given by way of illustration in relation to the drawings in which: FIG. 1 represents in section the teat according to the invention,
- la figure 2 représente une tétine montée sur un biberon standard avec un moyen d'injection contenant le produit à administrer.- Figure 2 shows a teat mounted on a standard bottle with an injection means containing the product to be administered.
La coupe de la tétine 1 représentée sur la figure 1 montre une tétine classique constituée d'une partie proximale P prolongée par un mamelon 2 percé à son extrémité, d'une partie distale D séparées par une partie médiane M. La partie médiane M peut se présentée soit, comme illustré sur la figure, sous la forme d'un renflement 3, soit sous une forme plus ou moins tubulaire. La partie distale est munie classiquement à sa base d'une ceinture 4 permettant son adaptation dans la bague du biberon. Bien entendu, la tétine est constituée d'un matériau traditionnellement utilisé dans la fabrication de ce genre de produit et répondant aux normes en vigueur. La tétine est équipée selon l'invention d'un manchon creux 5 fixé à une extrémité à la partie médiane M représentée le plus près possible de la ceinture 4 et de façon éloignée par rapport au mamelon 2 en débouchant dans le renflement 3. Avantageusement, le manchon 5 est réalisé dans le même matériau que celui de la tétine. L'extrémité libre 6 du manchon reçoit un moyen d'injection 7, une pipette par exemple. Ce manchon présente une forme tronconique, la grande base étant située au niveau de l'extrémité libre 6, qui permet d'assurer l'étanchéité vis à vis de l'air et du liquide pour tous les types de pipette. Selon une variante de réalisation non représentée, le manchon peut être constitué d'une partie tubulaire suivie d'une partie tronconique.The section of the teat 1 shown in Figure 1 shows a conventional teat consisting of a proximal part P extended by a nipple 2 pierced at its end, with a distal part D separated by a middle part M. The middle part M can be presented either, as illustrated in the figure, in the form of a bulge 3, or under a more or less tubular shape. The distal part is conventionally provided at its base with a belt 4 allowing its adaptation in the ring of the bottle. Of course, the teat is made of a material traditionally used in the manufacture of this kind of product and meeting the standards in force. The teat is equipped according to the invention with a hollow sleeve 5 fixed at one end to the middle part M shown as close as possible to the belt 4 and away from the nipple 2 by opening into the bulge 3. Advantageously, the sleeve 5 is made of the same material as that of the teat. The free end 6 of the sleeve receives an injection means 7, a pipette for example. This sleeve has a frustoconical shape, the large base being located at the free end 6, which ensures sealing against air and liquid for all types of pipette. According to an alternative embodiment not shown, the sleeve may consist of a tubular part followed by a frustoconical part.
Le manchon 5 constitue donc une partie intégrante de la tétine 1, ceci notamment dans le cas où le dispositif est fabriqué en un matériau, du type caoutchouc ou silicone, en une seule opération de moulage par injection. Ce manchon peut être placé de façon rectiligne par rapport à la tétine, mais on adoptera une forme courbe en arc de cercle dont la courbure est dirigée vers la tétine. Ainsi, ce manchon 5 peut être orienté de façon quelconque par rapport à la tétine, mais on préfère le placer suivant un angle α compris entre 30 et 90° par rapport à l'axe longitudinal XX de la tétine.The sleeve 5 therefore constitutes an integral part of the nipple 1, this in particular in the case where the device is made of a material, of the rubber or silicone type, in a single injection molding operation. This sleeve can be placed in a rectilinear manner with respect to the teat, but we will adopt a curved shape in an arc of a circle whose curvature is directed towards the teat. Thus, this sleeve 5 can be oriented in any way with respect to the teat, but it is preferred to place it at an angle α between 30 and 90 ° relative to the longitudinal axis XX of the teat.
La partie tronconique du manchon sera prévue de façon à ce que la majorité des pipettes commercialisées s'y adaptent à son extrémité libre à la fois facilement et y tienne de façon étanche à l'air et au liquide.The frustoconical part of the sleeve will be provided so that the majority of pipettes sold adapt to it at its free end both easily and holds there in an airtight and liquid tight manner.
La longueur et l'élasticité du manchon creux seront suffisantes pour maintenir le moyen d'injection même en le lâchant et aussi pour ne pas gêner la mise en place de la tétine dans la bague du biberon.The length and elasticity of the hollow sleeve will be sufficient to maintain the injection means even when letting go of it and also not to hinder the positioning of the teat in the ring of the bottle.
Bien entendu, la taille de la tétine sera suffisante pour que la bouche de l'enfant ne soit pas gênée par la naissance du manchon. On a schématisé sur cette figure le principe d'administration de la dose médicamenteuse selon l'invention. Lorsque la dose est injectée suivant la flèche F, il se forme dans la partie médiane M un volume V, dans lequel le mélange concentré est principalement localisé, qui est immédiatement aspiré par l'enfant dans les conditions normales d'utilisation. Il n'y a donc pas de reflux dans le biberon préjudiciable à une bonne administration du produit médicamenteux, ni injection au niveau de la partie proximale. Autour du volume V, il peut se former une zone v moins riche en produit médicamenteux, mais elle est également rapidement avalée par l'enfant.Of course, the size of the teat will be sufficient so that the child's mouth is not hampered by the birth of the sleeve. The principle of administration of the drug dose according to the invention is shown diagrammatically in this figure. When the dose is injected according to arrow F, a volume V is formed in the middle part M, in which the concentrated mixture is mainly located, which is immediately sucked up by the child under normal conditions of use. There is therefore no reflux in the bottle prejudicial to good administration of the drug product, nor injection at the level of the proximal part. Around the volume V, a zone v less rich in drug product can form, but it is also quickly swallowed by the child.
Sur la figure 2, on a représenté la mise en place d'un moyen d'injection 7 prérempli dans le manchon 5. Ce moyen peut être utilisé tel que représenté sur la figure ou être solidarisé de manière amovible avec le biberon 8 équipé de sa bague 10 pour en faciliter l'utilisation. Pour administrer la dose requise, il suffit de donner à l'enfant le biberon comme d'habitude, puis d'actionner le piston 9 du moyen d'injection 7 quand on le souhaite afin que le produit médicamenteux contenu se vide directement dans la partie médiane de la tétine pendant la tétée pour former le volume V.In Figure 2, there is shown the establishment of an injection means 7 pre-filled in the sleeve 5. This means can be used as shown in the figure or be removably secured with the bottle 8 equipped with its ring 10 for ease of use. To administer the required dose, simply give the child the bottle as usual, then actuate the piston 9 of the injection means 7 when desired so that the drug product contained empties directly into the part median of the nipple during feeding to form volume V.
Lorsque l'enfant prend son biberon, l'utilisateur n'a plus qu'à appuyer, le moment choisi, sur le piston et le produit médicamenteux se videra à proximité immédiate de l'orifice de sortie de la tétine 1 en se mélangeant au repas de l'enfant au niveau de la partie médiane. Sur la figure, on a représenté la zone (a) dans laquelle est localisé le volume V de mélange médicamenteux, c'est-à-dire la tétine, et la zone (b) dans laquelle le produit médicamenteux ne peut pas migrer, c'est-à-dire le biberon.When the child takes his bottle, the user only has to press, the chosen moment, on the piston and the drug product will empty in the immediate vicinity of the teat 1 outlet orifice, mixing with the meal of the child at the middle part. In the figure, there is shown the area (a) in which the volume V of the drug mixture, i.e. the teat, is located, and the area (b) in which the drug product cannot migrate, c that is to say the bottle.
L'invention permet donc l'administration de liquides médicamenteux ou autres à l'aide d'une tétine en étant certain de la prise complète du produit en limitant les causes habituelles de refus de l'enfant (goût et odeur). Le produit ainsi administré ne restera que peu de temps dans la tétine et sera vite avalé. Il ne restera plus de trace gustative après l'administration. The invention therefore allows the administration of medicated or other liquids using a teat while being certain of the complete intake of the product while limiting the usual causes of refusal of the child (taste and odor). The product thus administered will only remain in the teat for a short time and will be quickly swallowed. There will no longer be any traces of taste after administration.

Claims

REVENDICATIONS
1 - Tétine (1) pour biberon d'enfant du type comportant une partie proximale P prolongée par un mamelon (2) et une partie distale D séparées par une partie médiane M pour l'administration d'un produit médicamenteux conjointement avec le bol alimentaire, caractérisée en ce qu'elle comporte un manchon creux (5) dont une extrémité est fixée à la partie médiane M pour déboucher dans celle-ci en un point éloigné de la partie proximale P et dont l'autre extrémité (6) est connectée à un moyen d'injection (7) du produit médicamenteux, pour assurer un mélange du produit médicamenteux avec la partie du bol alimentaire contenue dans la partie médiane de la tétine.1 - Teat (1) for a baby bottle of the type comprising a proximal part P extended by a nipple (2) and a distal part D separated by a middle part M for the administration of a medicinal product together with the food bolus , characterized in that it comprises a hollow sleeve (5), one end of which is fixed to the central part M to open into the latter at a point distant from the proximal part P and the other end (6) of which is connected to a means for injecting (7) the drug product, to ensure mixing of the drug product with the part of the food bolus contained in the middle part of the teat.
2 - Tétine selon la revendication 1, caractérisée en ce que le manchon (5) est intégré à la partie médiane M pour constituer une pièce unique.2 - Teat according to claim 1, characterized in that the sleeve (5) is integrated into the middle part M to form a single piece.
3 - Tétine selon la revendication 1 ou 2, caractérisée en ce que l'extrémité du manchon (5) liée au moyen d'injection (5) présente un profil tronconique pour permettre l'insertion graduelle dudit moyen d'injection.3 - Teat according to claim 1 or 2, characterized in that the end of the sleeve (5) connected to the injection means (5) has a frustoconical profile to allow the gradual insertion of said injection means.
4 - Tétine selon l'une quelconque des revendications 1 à 3, caractérisé en ce que le manchon (5) est implanté de façon suffisamment éloignée de la partie proximale P pour éviter toute gène du processus de tétée. 5- Tétine selon l'une quelconque des revendications précédentes, caractérisée en ce que l'angle α d'implantation du manchon (5) sur la partie médiane M est compris entre environ 30 et 90°.4 - Teat according to any one of claims 1 to 3, characterized in that the sleeve (5) is implanted sufficiently distant from the proximal part P to avoid any gene in the feeding process. 5- pacifier according to any one of the preceding claims, characterized in that the angle α of implantation of the sleeve (5) on the middle part M is between approximately 30 and 90 °.
6 - Tétine selon l'une quelconque des revendications précédentes, caractérisée en ce que le manchon (4) est réalisé dans le même matériau que celui de la tétine elle- même.6 - Teat according to any one of the preceding claims, characterized in that the sleeve (4) is made of the same material as that of the teat itself.
7 - Tétine selon l'une quelconque des revendications précédentes, caractérisée en ce que la partie médiane M se présente sous la forme d'un renflement (3). 7 - Teat according to any one of the preceding claims, characterized in that the middle part M is in the form of a bulge (3).
EP99942982A 1999-09-15 1999-09-15 Nipple for nursing bottle Expired - Lifetime EP1128796B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FR1999/002200 WO2001019319A1 (en) 1999-09-15 1999-09-15 Nipple for nursing bottle

Publications (2)

Publication Number Publication Date
EP1128796A1 true EP1128796A1 (en) 2001-09-05
EP1128796B1 EP1128796B1 (en) 2004-01-14

Family

ID=9542389

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99942982A Expired - Lifetime EP1128796B1 (en) 1999-09-15 1999-09-15 Nipple for nursing bottle

Country Status (5)

Country Link
EP (1) EP1128796B1 (en)
AT (1) ATE257685T1 (en)
AU (1) AU5629099A (en)
DE (1) DE69914217D1 (en)
WO (1) WO2001019319A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT409717B (en) * 2001-05-23 2002-10-25 Walderdorff Philipp Dr Oral medicament applicator incorporates an outlet opening whose cross section is larger than the clear interior cross section of the delivery hose
US9510562B2 (en) 2013-07-10 2016-12-06 Chris's Squirrels and More, LLC Feeding nipple
US11969395B2 (en) * 2022-01-31 2024-04-30 Lauren Nicole Hunter Feeding nipple with penetrable side entry tube for administration of liquid medicine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2680441A (en) 1952-03-11 1954-06-08 Krammer Robert Nursing bottle attachment
AP39A (en) * 1986-01-08 1989-04-20 Stephen Roskilly Improvements ralating to baby feeding bottles.
US5178291A (en) 1992-03-30 1993-01-12 Piercey Vickie D Nursing lid construction for a nursing bottle
FR2775896B1 (en) * 1998-03-13 2000-12-29 L Arc Hubert Andre De LIQUID DELIVERY DEVICE THROUGH A STANDARD BOTTLE TAP

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0119319A1 *

Also Published As

Publication number Publication date
WO2001019319A1 (en) 2001-03-22
ATE257685T1 (en) 2004-01-15
DE69914217D1 (en) 2004-02-19
AU5629099A (en) 2001-04-17
EP1128796B1 (en) 2004-01-14

Similar Documents

Publication Publication Date Title
JP3953108B2 (en) Drug administration comfort device
FR2503565A1 (en) SINGLE BODY ASSEMBLY AND TWO MEDICATION COMPARTMENTS
US6270519B1 (en) Nipple for use with liquid and medicine dispensing bottle
CN1191808C (en) Teat nozzle for dosing device with connection means
JPH09215754A (en) Tool used for liquid for medical use and connector used for the same
EP0403626A1 (en) Storage and transfer bottle designed for storing two components of a medicamental substance.
MXPA99004727A (en) Nursing bottle with medication dispenser.
FR3009495A3 (en) LIQUID TRANSFER DEVICES FOR USE WITH INFUSION LIQUID CONTAINERS
JP2002506687A (en) Nipple for pacifier
TW201143758A (en) Syringe filter cap and method of using the same for administration of medication dosage
US20130085475A1 (en) Medicated And Flavored Pacifier
WO1997020536A1 (en) Device for preparing a medicinal solution reconstituted from two components
EP1034772A1 (en) Device for transfering a substance contained in a vial to a pouch containing a solute
BE570564A (en)
EP1128796B1 (en) Nipple for nursing bottle
CN203598241U (en) Feeder type injection medicine feeding device
EP1581161A1 (en) Pacifier for administering flavour substances
FR2817465A1 (en) RECONSTRUCTION DEVICE, PARTICULARLY FOR MIXING SUBSTANCES IN THE MEDICAL FIELD
US4959051A (en) Dual chambered oral dosage delivery container
FR2613220A1 (en) NEEDLE ASSEMBLY FOR THE TRANSFER OF LIQUIDS
WO2009033202A1 (en) Liquid medication dispensing device for a child
EP1507742B1 (en) Device for filling a flexible pouch
US20150148740A1 (en) System for an interchangeable nipple for a pacifier
EP2210580B1 (en) Nozzle for the administration of a liquid solution in a nostril
FR2775896A1 (en) Liquid administration device used with dummy on ordinary baby bottles

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010503

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040114

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20040114

Ref country code: IE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040114

Ref country code: GB

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040114

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040114

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040114

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040114

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: FRENCH

REF Corresponds to:

Ref document number: 69914217

Country of ref document: DE

Date of ref document: 20040219

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040414

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040414

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040415

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20040425

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20040114

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
GBV Gb: ep patent (uk) treated as always having been void in accordance with gb section 77(7)/1977 [no translation filed]

Effective date: 20040114

REG Reference to a national code

Ref country code: IE

Ref legal event code: FD4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040915

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040930

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040930

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040930

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040930

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20041015

BERE Be: lapsed

Owner name: *ANDRE DE L'ARC HUBERT

Effective date: 20040930

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

BERE Be: lapsed

Owner name: *ANDRE DE L'ARC HUBERT

Effective date: 20040930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040614

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 18

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 19

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20180921

Year of fee payment: 20